1,3-dimethylbenzimidazoline-2-thione has been researched along with 17-alpha-hydroxyprogesterone in 1 studies
| Studies (1,3-dimethylbenzimidazoline-2-thione) | Trials (1,3-dimethylbenzimidazoline-2-thione) | Recent Studies (post-2010) (1,3-dimethylbenzimidazoline-2-thione) | Studies (17-alpha-hydroxyprogesterone) | Trials (17-alpha-hydroxyprogesterone) | Recent Studies (post-2010) (17-alpha-hydroxyprogesterone) |
|---|---|---|---|---|---|
| 7 | 0 | 1 | 2,148 | 145 | 434 |
| Protein | Taxonomy | 1,3-dimethylbenzimidazoline-2-thione (IC50) | 17-alpha-hydroxyprogesterone (IC50) |
|---|---|---|---|
| Glucocorticoid receptor | Homo sapiens (human) | 0.051 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.051 | |
| Adenosine receptor A3 | Homo sapiens (human) | 4.73 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 6.3 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 0.739 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 4.73 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.051 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.051 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.051 | |
| Mitogen-activated protein kinase 3 | Homo sapiens (human) | 3.157 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 4.73 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 6.905 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
1 other study(ies) available for 1,3-dimethylbenzimidazoline-2-thione and 17-alpha-hydroxyprogesterone
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |